Clinical Study Aiming to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Administration of ZE50-0134 at 5 Dose Levels in Healthy Volunteers
Lomond Therapeutics Holdings, Inc.
Lomond Therapeutics Holdings, Inc.
Kura Oncology, Inc.
Ipsen
Hospital Universitario Dr. Jose E. Gonzalez
Jonsson Comprehensive Cancer Center
Xian-Janssen Pharmaceutical Ltd.
Zhejiang University
Fred Hutchinson Cancer Center